Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins

Background: Cross-reactivity against human coronaviruses with Flebogamma(®) DIF and Gamunex(®)-C, two available intravenous immunoglobulins (IVIG), has been reported. In this study, these IVIG were tested for neutralization activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Díez, José María, Romero, Carolina, Vergara-Alert, Júlia, Belló-Perez, Melissa, Rodon, Jordi, Honrubia, José Manuel, Segalés, Joaquim, Sola, Isabel, Enjuanes, Luis, Gajardo, Rodrigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480323/
https://www.ncbi.nlm.nih.gov/pubmed/32900263
http://dx.doi.org/10.2217/imt-2020-0220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480323/
https://www.ncbi.nlm.nih.gov/pubmed/32900263
http://dx.doi.org/10.2217/imt-2020-0220

Ejemplares similares